SCHEMBL7832200

SCHEMBL7832200

Cc1[c]ccc([N+](=O)[O-])c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 6/20 0.50
ALDH1A1 P00352 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
ERN1 O75460 1/20 0.41
HSD17B10 Q99714 1/20 0.39
CTSB P07858 1/20 0.39
CTSH P09668 1/20 0.39
CYP3A4 P08684 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
GLA P06280 1/20 0.39
POLB P06746 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 2/20 0.38
CRHBP P24387 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9336847 0.80 GPR35 (0.54) GPR35ALDH1A1TDP1ERN1HSD17B10
SCHEMBL1173852 0.80 TDP1 (0.54) GPR35ALDH1A1TDP1HSD17B10CYP3A4
SCHEMBL2289877 0.78 TSHR (0.50) GPR35ALDH1A1TDP1HSD17B10CYP3A4
SCHEMBL6676890 0.78 GPR35 (0.52) GPR35ALDH1A1TDP1ERN1HSD17B10
SCHEMBL28123479 0.77 TDP1 (0.47) GPR35ALDH1A1TDP1HSD17B10CYP3A4
SCHEMBL8922502 0.77 CYP1A2 (0.43) GPR35ALDH1A1TDP1HSD17B10CYP3A4
SCHEMBL13836016 0.74 TDP1 (0.52) GPR35ALDH1A1TDP1HSD17B10CYP3A4
SCHEMBL9358697 0.74 MAPT (0.47) GPR35ALDH1A1TDP1HSD17B10CTSB
SCHEMBL8831878 0.73 AR (0.43) ALDH1A1TDP1HSD17B10CYP3A4CYP1A2
SCHEMBL8374 0.72 TDP1 (0.54) GPR35ALDH1A1TDP1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1144393-A3 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2002-09-11 EP disclosed
EP-1144393-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR AstraZeneca AB (SE) 2001-10-17 EP disclosed
WO-2000005224-A2 HETEROCYCLIC DERIVATIVES AND THEIR USE AS INTEGRIN INHIBITOR ASTRAZENECA AB (SE) 2000-02-03 WO disclosed